The influence of residual apixaban on bleeding complications during and after catheter ablation of atrial fibrillation
Background: The periprocedural protocol for atrial fibrillation (AF) ablation commonly includes anticoagulation therapy. Apixaban, a direct oral anticoagulant, is currently approved for clinical use; however, little is known about the effects of residual apixaban concentration on bleeding complicati...
Main Authors: | Yutaro Mukai, Kyoichi Wada, Koji Miyamoto, Kazuki Nakagita, Mai Fujimoto, Kouichi Hosomi, Takeshi Kuwahara, Mitsutaka Takada, Kengo Kusano, Akira Oita |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-10-01
|
Series: | Journal of Arrhythmia |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1880427617301230 |
Similar Items
-
Apixaban
by: Gianluca Airoldi, et al.
Published: (2013-03-01) -
Rectus sheath hematoma associated with apixaban
by: Kulothungan Gunasekaran, et al.
Published: (2017-08-01) -
Thrombocytopenia: A possible side effect of apixaban
by: Farid Sadaka
Published: (2019-12-01) -
Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathways
by: Andrea Huppertz, et al.
Published: (2019-08-01) -
Intracranial Hemorrhage following Lumbar Puncture in a Patient on Apixaban
by: Priyanka Vijapura, et al.
Published: (2019-09-01)